0 156

Cited 0 times in

The Efficacy and Safety of Cyclosporin A(Cipol-N soft capsule) in Adult Nephrotic Syndrome : 16 Weeks, Open Label, Multicenter Study

Other Title
신증후군환자에 대한 사이크로스포린의 유효성 및 안전성 평가를 위한 16주 공개 다기관 제 3상 임상시험
Authors
Lee, HY; Shin, SK; Noh, HJ; Kim, HS; Shin, GT; Kim, DH; Kim, YL; Cho, DK; Hong, SP; Lee, TW; Ihm, CG; Kim, MJ
Citation
Taehan Sinjang Hakhoe chi, 19(2):249-258, 2000
Journal Title
Taehan Sinjang Hakhoe chi; The Korean journal of nephrology; 대한신장학회지
ISSN
1225-0015
Abstract
A multicenter prospective study was done in four-university hospital to evaluate the

efficacy and safety of cyclosporin A(CyA, Cipol-N ) in 64 patients with adult nephrotic syndrome [mean age 34.8 years, male:famale 2.4:1, duration of desease

38.0±40.9months, 31 patients with MCD, 33 patients with Non-MCD(8 FSGS, 14 MGN,

7 MPGN, 2 lupus nephritis, 1 HBsAg associated GN)]. The prior steroid responses of these patients were 17 steroid dependent, 9 frequent relapser, 4 steroid resistant and 1 other in MCD patients, and 5 steroid dependent, 5 frequent relapser, 22 steroid resistant and 1 other in Non-MCD patients. After a 2-week steroid(prednisolon 10㎎/day or deflazacor 12㎎/day) run-in period, CyA 5㎎/㎏/day and prednisolone 10㎎/day(or

deflazacor 12㎎/day) were administered for up to 16 weeks. Of the 64 patients enrolled,

11 patients were dropped out prematurely due to adverse events or protocol violation. Of

the 53 patients who completed the study, 27 had MCD and 26 had Non-MCD.

High response(CR and PR) rate of 68%(36/53) were obtained with CyA treatment in all patients. Although the response late in MCD was significantly higher than that in

Non-MCD(89 vs. 46%, p<0.05) and response rates were significantly different according

to the previous steroid responses by univariate analysis, only previous steroid responses affected the response to CyA significantly by Logistic multiple regression analysis(p=0.03, RR 7.08); responses were 84%(27/32) in steroid dependent and frequent relapser patients, and 37%(7/19) in steroid resistant patients. 24-hr proteinuria significantly decreased after 2 weeks and serum albumin and cholesterol increased significantly after 4 weeks of treatment compared to baseline level. The serum creatinine level was not changed during the study. No serious and unexpected side event was observed.

In conclusion, cyclosporine therapy is a safe and effective mode of treatment in

patients with nephrotic syndrome, especially in those who need prolonged administration

of steroids with resulting in unavoidable steroid complications such as frequent relapser and steroid dependent type. The patients with steroid resistant type and

contraindications of steroid administration such as DM, aseptic bone necrosis etc. can

also be candidates for this treatment.
Keywords
CyclosporinNephrotic syndrome
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Nephrology
Full Text Link
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse